These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 29247719)
1. Developmental changes of l-arginine transport at the blood-brain barrier in rats. Tachikawa M; Hirose S; Akanuma SI; Matsuyama R; Hosoya KI Microvasc Res; 2018 May; 117():16-21. PubMed ID: 29247719 [TBL] [Abstract][Full Text] [Related]
2. Cationic amino acid transporter 1-mediated L-arginine transport at the inner blood-retinal barrier. Tomi M; Kitade N; Hirose S; Yokota N; Akanuma S; Tachikawa M; Hosoya K J Neurochem; 2009 Nov; 111(3):716-25. PubMed ID: 19712052 [TBL] [Abstract][Full Text] [Related]
3. Impact of Cationic Amino Acid Transporter 1 on Blood-Retinal Barrier Transport of L-Ornithine. Kubo Y; Obata A; Akanuma S; Hosoya K Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5925-32. PubMed ID: 26377079 [TBL] [Abstract][Full Text] [Related]
4. Characteristics of Lee KE; Kang YS J Biomed Sci; 2017 May; 24(1):28. PubMed ID: 28490336 [TBL] [Abstract][Full Text] [Related]
5. Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1). Strobel J; Mieth M; Endress B; Auge D; König J; Fromm MF; Maas R J Mol Cell Cardiol; 2012 Sep; 53(3):392-400. PubMed ID: 22705145 [TBL] [Abstract][Full Text] [Related]
6. The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood-brain barrier in vitro. Watson CP; Pazarentzos E; Fidanboylu M; Padilla B; Brown R; Thomas SA Brain Res; 2016 Oct; 1648(Pt A):232-242. PubMed ID: 27431938 [TBL] [Abstract][Full Text] [Related]
7. Effects of simvastatin on CAT-1-mediated arginine transport and NO level under high glucose conditions in conditionally immortalized rat inner blood-retinal barrier cell lines (TR-iBRB). Tun T; Kang YS Microvasc Res; 2017 May; 111():60-66. PubMed ID: 28089735 [TBL] [Abstract][Full Text] [Related]
8. The prognostic biomarker L-homoarginine is a substrate of the cationic amino acid transporters CAT1, CAT2A and CAT2B. Chafai A; Fromm MF; König J; Maas R Sci Rep; 2017 Jul; 7(1):4767. PubMed ID: 28684763 [TBL] [Abstract][Full Text] [Related]
9. The l-isomer-selective transport of aspartic acid is mediated by ASCT2 at the blood-brain barrier. Tetsuka K; Takanaga H; Ohtsuki S; Hosoya K; Terasaki T J Neurochem; 2003 Nov; 87(4):891-901. PubMed ID: 14622120 [TBL] [Abstract][Full Text] [Related]
10. Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+. O'Kane RL; Viña JR; Simpson I; Zaragozá R; Mokashi A; Hawkins RA Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E412-9. PubMed ID: 16569760 [TBL] [Abstract][Full Text] [Related]
11. Screening of commonly prescribed drugs for effects on the CAT1-mediated transport of L-arginine and arginine derivatives. Banjarnahor S; König J; Maas R Amino Acids; 2022 Jul; 54(7):1101-1108. PubMed ID: 35377022 [TBL] [Abstract][Full Text] [Related]
12. Augmented arginine uptake, through modulation of cationic amino acid transporter-1, increases GFR in diabetic rats. Schwartz IF; Iaina A; Benedict Y; Wollman Y; Chernichovski T; Brasowski E; Misonzhnik F; Ben-Dor A; Blum M; Levo Y; Schwartz D Kidney Int; 2004 Apr; 65(4):1311-9. PubMed ID: 15086470 [TBL] [Abstract][Full Text] [Related]
13. Protein kinase C restricts transport of carnitine by amino acid transporter ATB(0,+) apically localized in the blood-brain barrier. Michalec K; Mysiorek C; Kuntz M; Bérézowski V; Szczepankiewicz AA; Wilczyński GM; Cecchelli R; Nałęcz KA Arch Biochem Biophys; 2014 Jul; 554():28-35. PubMed ID: 24823859 [TBL] [Abstract][Full Text] [Related]
14. Changes of differentiation and proliferation in k562 cells with various levels of knockdown of cationic amino acid transporter 1. Maeda T; Shima Y; Sugiura S; Aizawa S; Tamai I Drug Metab Pharmacokinet; 2008; 23(3):181-7. PubMed ID: 18574322 [TBL] [Abstract][Full Text] [Related]
15. L-arginine transport and nitric oxide synthesis in human endothelial progenitor cells. Díaz-Pérez F; Radojkovic C; Aguilera V; Veas C; González M; Lamperti L; Escudero C; Aguayo C J Cardiovasc Pharmacol; 2012 Nov; 60(5):439-49. PubMed ID: 23143655 [TBL] [Abstract][Full Text] [Related]
16. Arginine uptake is attenuated, through post-translational regulation of cationic amino acid transporter-1, in hyperlipidemic rats. Schwartz IF; Ingbir M; Chernichovski T; Reshef R; Chernin G; Litvak A; Weinstein T; Levo Y; Schwartz D Atherosclerosis; 2007 Oct; 194(2):357-63. PubMed ID: 17178122 [TBL] [Abstract][Full Text] [Related]
17. Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats. Hoffmann K; Löscher W Epilepsia; 2007 Apr; 48(4):631-45. PubMed ID: 17437408 [TBL] [Abstract][Full Text] [Related]
18. Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport. Li C; Huang W; Harris MB; Goolsby JM; Venema RC Biochem J; 2005 Mar; 386(Pt 3):567-74. PubMed ID: 15743275 [TBL] [Abstract][Full Text] [Related]
19. Quantitative Determination of Luminal and Abluminal Membrane Distributions of Transporters in Porcine Brain Capillaries by Plasma Membrane Fractionation and Quantitative Targeted Proteomics. Kubo Y; Ohtsuki S; Uchida Y; Terasaki T J Pharm Sci; 2015 Sep; 104(9):3060-8. PubMed ID: 25703048 [TBL] [Abstract][Full Text] [Related]
20. Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress. Zhang WZ; Venardos K; Chin-Dusting J; Kaye DM Hypertension; 2006 Aug; 48(2):278-85. PubMed ID: 16801489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]